Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture

被引：0
|
作者：
L. Jacob
M. Dreher
K. Kostev
P. Hadji
机构：
[1] École Normale Supérieure de Lyon,Department of Biology
[2] Philipps-Universität Marburg,Department of Gynecology and Obstetrics
[3] IMS Health Epidemiology,Nordwest Hospital
[4] Philipps-University of Marburg,undefined
来源：
Osteoporosis International | 2016年 / 27卷
关键词：
Fracture; Osteoporosis; Pain; Persistence; Therapy discontinuation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：963 / 969
页数：6
相关论文
共 50 条
  • [31] Low frequency of treatment of osteoporosis among postmenopausal women following a fracture
    Andrade, SE
    Majumdar, SR
    Chan, KA
    Buist, DSM
    Go, AS
    Goodman, M
    Smith, DH
    Platt, R
    Gurwitz, JH
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (17) : 2052 - 2057
  • [32] Diagnosis and treatment of osteoporosis in postmenopausal women with distal radius fracture in Germany
    Endres, Heinz G.
    Dasch, Burkhard
    Maier, Christoph
    Lungenhausen, Margitta
    Smektala, Ruediger
    Trampisch, Hans J.
    Pientka, Ludger
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) : 2171 - 2181
  • [33] Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture
    Follin, SL
    Black, JN
    McDermott, MT
    PHARMACOTHERAPY, 2003, 23 (02): : 190 - 198
  • [34] Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service
    Delbar, Anthony
    Pflimlin, Arnaud
    Delabriere, Isabelle
    Ternynck, Camille
    Chantelot, Christophe
    Puisieux, Francois
    Cortet, Bernard
    Paccou, Julien
    BONE, 2021, 144
  • [35] PERSISTENCE WITH OSTEOPOROSIS TREATMENT IN PATIENTS FROM THE LILLE UNIVERSITY HOSPITAL FRACTURE LIAISON SERVICE
    Delbar, A.
    Paccou, J.
    Pflimlin, A.
    Delabriere, I.
    Ternynck, C.
    Chantelot, C.
    Puisieux, F.
    Cortet, B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S150 - S151
  • [36] Recognizing osteoporosis and its consequences in Quebec (ROCQ): Fragility fracture rate among women who sustained a fracture
    Brown, JP
    Bessette, L
    Beaulieu, M
    Sauriol, L
    Jean, S
    Davison, SK
    Ste-Marie, L
    BONE, 2005, 36 : S350 - S350
  • [37] TIME TO ONSET OF ANTI-FRACTURE EFFICACY AND PERSISTENCE OF EFFECT OF ZOLEDRONIC ACID 5 MG IN WOMEN WITH OSTEOPOROSIS OR RECENT HIP FRACTURE
    Black, D. M.
    Boonen, S.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S272 - S272
  • [38] Time to onset of anti-fracture efficacy and persistence of effect of zoledronic acid 5 mg in women with osteoporosis or recent hip fracture
    Black, D. M.
    Eastell, R.
    Boonen, S.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    BONE, 2009, 44 (02) : S241 - S242
  • [39] Persistence and its determinants among elderly women initiating osteoporosis therapies for secondary prevention
    Blouin, J.
    Dragomir, A.
    Ste-Marie, L. G.
    Fernandes, J. C.
    Perreault, S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S236 - S237
  • [40] Persistence and its determinants among elderly women initiating osteoporosis therapies for primary prevention
    Blouin, J.
    Dragomir, A.
    Ste-Marie, L. G.
    Fernandes, J. C.
    Perreault, S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S240 - S241
12345